MNKD - MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for
MNKD - MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease - Click For Release
Story updates
10:32:30 AM UTC
SquawkNews
MNKD Mannkind announces FDA approval of furoscix readyflow™, the first and only autoinjector delivering Iv-equivalent diuretic therapy for the treatment of edema in adults with heart failure or chronic kidney disease Mannkind Corp - furoscix readyflow expected to be available in U.S. by end of Augus
10:37:11 AM UTC
SquawkNews
MannKind announced that...
MNKD Mannkind announces FDA approval of furoscix readyflow™, the first and only autoinjector delivering Iv-equivalent diuretic therapy for the treatment of edema in adults with heart failure or chronic kidney disease Mannkind Corp - furoscix readyflow expected to be available in U.S. by end of August 2026